Physician
Nadpara, Kajal
Nadpara, Kajal was paid $178K by Medicaid between Dec 2018 and Sep 2024, across 9 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoNADPARA, KAJAL
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1114123742assigned 06/21/2007
33bProvider typeFamily Medicine Physician
28Total paid$178K
24GClaims1,808
24DCodes billed9
24AFirst – last monthDec 2018 – Sep 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#433 of 2,605
Median peer was paid$10K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $342.48 | |
| 2019 | 144 | $9K | |
| 2020 | 296 | $25K | |
| 2021 | 347 | $37K | |
| 2022 | 664 | $78K | |
| 2023 | 283 | $26K | |
| 2024incomplete | 61 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 788 | 780 | $56K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 28% | 366 | 366 | $49K |
| S9083 | Global fee urgent care centers | 24% | 283 | 281 | $42K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 278 | 276 | $23K |
| 87631 | 1.8% | 27 | 27 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 29 | 29 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 12 | 12 | $837.30 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | 13 | $667.03 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | 12 | $387.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.